Acadian Asset Management’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $241K | Sell |
27,366
-5,679
| -17% | -$50K | ﹤0.01% | 1276 |
|
|
2025
Q1 | $354K | Buy |
33,045
+22,181
| +204% | +$238K | ﹤0.01% | 1146 |
|
|
2024
Q4 | $139K | Buy |
+10,864
| New | +$139K | ﹤0.01% | 1312 |
|
|
2024
Q2 | – | Sell |
-3,898
| Closed | -$173K | – | 1846 |
|
|
2024
Q1 | $173K | Buy |
+3,898
| New | +$173K | ﹤0.01% | 1205 |
|